Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans
- 22 January 2007
- journal article
- review article
- Published by Hindawi Limited in Human Mutation
- Vol. 28 (3), 209-221
- https://doi.org/10.1002/humu.20429
Abstract
Osteogenesis imperfecta (OI) is a generalized disorder of connective tissue characterized by fragile bones and easy susceptibility to fracture. Most cases of OI are caused by mutations in type I collagen. We have identified and assembled structural mutations in type I collagen genes (COL1A1 and COL1A2, encoding the proα1(I) and proα2(I) chains, respectively) that result in OI. Quantitative defects causing type I OI were not included. Of these 832 independent mutations, 682 result in substitution for glycine residues in the triple helical domain of the encoded protein and 150 alter splice sites. Distinct genotype–phenotype relationships emerge for each chain. One‐third of the mutations that result in glycine substitutions in α1(I) are lethal, especially when the substituting residues are charged or have a branched side chain. Substitutions in the first 200 residues are nonlethal and have variable outcome thereafter, unrelated to folding or helix stability domains. Two exclusively lethal regions (helix positions 691–823 and 910–964) align with major ligand binding regions (MLBRs), suggesting crucial interactions of collagen monomers or fibrils with integrins, matrix metalloproteinases (MMPs), fibronectin, and cartilage oligomeric matrix protein (COMP). Mutations in COL1A2 are predominantly nonlethal (80%). Lethal substitutions are located in eight regularly spaced clusters along the chain, supporting a regional model. The lethal regions align with proteoglycan binding sites along the fibril, suggesting a role in fibril–matrix interactions. Recurrences at the same site in α2(I) are generally concordant for outcome, unlike α1(I). Splice site mutations comprise 20% of helical mutations identified in OI patients, and may lead to exon skipping, intron inclusion, or the activation of cryptic splice sites. Splice site mutations in COL1A1 are rarely lethal; they often lead to frameshifts and the mild type I phenotype. In α2(I), lethal exon skipping events are located in the carboxyl half of the chain. Our data on genotype–phenotype relationships indicate that the two collagen chains play very different roles in matrix integrity and that phenotype depends on intracellular and extracellular events. Hum Mutat 28(3), 209–221, 2007. Published 2006 Wiley‐Liss, Inc.Keywords
This publication has 75 references indexed in Scilit:
- Total absence of the 2(I) chain of collagen type I causes a rare form of Ehlers-Danlos syndrome with hypermobility and propensity to cardiac valvular problemsJournal of Medical Genetics, 2005
- Procollagen trafficking, processing and fibrillogenesisJournal of Cell Science, 2005
- Stability related bias in residues replacing glycines within the collagen triple helix (Gly-Xaa-Yaa) in inherited connective tissue disordersHuman Mutation, 2004
- Nomenclature for the description of human sequence variationsHuman Genetics, 2001
- Hydrolysis of Triple-helical Collagen Peptide Models by Matrix MetalloproteinasesPublished by Elsevier BV ,2000
- Inhibition of the Self-assembly of Collagen I into Fibrils with Synthetic Peptides: DEMONSTRATION THAT ASSEMBLY IS DRIVEN BY SPECIFIC BINDING SITES ON THE MONOMERSPublished by Elsevier BV ,1998
- Fibronectin binding site in type I collagen regulates fibronectin fibril formation.The Journal of cell biology, 1993
- Type I procollagen: The gene‐protein system that harbors most of the mutations causing osteogenesis imperfecta and probably more common heritable disorders of connective tissueAmerican Journal of Medical Genetics, 1989
- Heritable Diseases of CollagenThe New England Journal of Medicine, 1984
- Localization of the cell attachment region in types I and II collagensBiochemical and Biophysical Research Communications, 1976